As of 2025-12-28, the Relative Valuation of Abbvie Inc (ABBV) is 37.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 229.98 USD, the upside of Abbvie Inc based on Relative Valuation is -83.5%.
The range of the Relative Valuation is 24.51 - 53.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 25.5x | 20.2x |
| Forward P/E multiples | 19.6x - 23.0x | 21.0x |
| Fair Price | 24.51 - 53.17 | 37.92 |
| Upside | -89.3% - -76.9% | -83.5% |
| Date | P/E |
| 2025-12-26 | 170.21 |
| 2025-12-24 | 170.14 |
| 2025-12-23 | 169.33 |
| 2025-12-22 | 168.68 |
| 2025-12-19 | 167.87 |
| 2025-12-18 | 164.91 |
| 2025-12-17 | 166.01 |
| 2025-12-16 | 165.54 |
| 2025-12-15 | 168.34 |
| 2025-12-12 | 165.28 |
| 2025-12-11 | 165.77 |
| 2025-12-10 | 166.66 |
| 2025-12-09 | 165.04 |
| 2025-12-08 | 165.13 |
| 2025-12-05 | 167.32 |
| 2025-12-04 | 169.27 |
| 2025-12-03 | 170.40 |
| 2025-12-02 | 166.06 |
| 2025-12-01 | 166.61 |
| 2025-11-28 | 168.52 |
| 2025-11-26 | 168.49 |
| 2025-11-25 | 171.56 |
| 2025-11-24 | 169.86 |
| 2025-11-21 | 174.87 |
| 2025-11-20 | 169.82 |
| 2025-11-19 | 172.38 |
| 2025-11-18 | 173.09 |
| 2025-11-17 | 173.19 |
| 2025-11-14 | 171.97 |
| 2025-11-13 | 171.92 |
| 2025-11-12 | 172.62 |
| 2025-11-11 | 166.65 |
| 2025-11-10 | 161.87 |
| 2025-11-07 | 162.20 |
| 2025-11-06 | 162.11 |
| 2025-11-05 | 160.43 |
| 2025-11-04 | 159.78 |
| 2025-11-03 | 156.87 |
| 2025-10-31 | 161.37 |
| 2025-10-30 | 168.89 |
| 2025-10-29 | 166.63 |
| 2025-10-28 | 168.40 |
| 2025-10-27 | 168.77 |
| 2025-10-24 | 168.74 |
| 2025-10-23 | 168.93 |
| 2025-10-22 | 169.25 |
| 2025-10-21 | 171.25 |
| 2025-10-20 | 171.75 |
| 2025-10-17 | 169.91 |
| 2025-10-16 | 167.91 |